Positron Corp (POSC) Stock Price & Analysis
Positron Corp (POSC) fell 1.59% to USD 1.86 as of June 10, 2026 at 14:11 UTC, according to Nexqual real-time market data.
POSC last closed at USD 1.89; the session ranged USD 1.86–1.89 on volume of 10,039 shares. Market capitalization is $61.09M, with a 52-week range of USD 1.25–2.74 (OID). Source: Nexqual, June 10, 2026 at 14:11 UTC.
Key Statistics (as of June 10, 2026 at 14:11 UTC)
| Price | USD 1.86 |
|---|---|
| Change | ▼ 1.59% (down) |
| Previous Close | USD 1.89 |
| Open | USD 1.89 |
| Day Range | USD 1.86 – 1.89 |
| 52-Week Range | USD 1.25 – 2.74 |
| Volume | 10,039 shares |
| Market Cap | $61.09M |
| Exchange | OID |
Technical Analysis (POSC)
Nexqual's technical model rates POSC "NEUTRAL" based on 2 bullish and 3 bearish signals across 124 daily candles, as of June 10, 2026 at 14:11 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 48.14 (neutral) |
| vs SMA50 | Above (USD 1.84) |
| MACD | 0.01 (positive) |
Analyst Ratings (POSC)
Wall Street analysts rate POSC "None", per Nexqual as of June 10, 2026 at 14:11 UTC.
| Consensus Rating | None |
|---|
Earnings (POSC)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2011-12-31 | USD 0 vs est 0 ▲ beat |
| 2011-09-30 | USD 0 vs est 0 ▲ beat |
Source: Nexqual, June 10, 2026 at 14:11 UTC.
Financials & Fundamentals (POSC)
| Total Revenue | $453,119 |
|---|---|
| Revenue Growth (YoY) | -7.00% |
| Gross Margin | +0.00% |
| Operating Margin | -1229.69% |
| Profit Margin | +0.00% |
| Debt / Equity | 655.27 |
| Current Ratio | 0.87 |
| Total Cash | $1.41M |
| Total Debt | $1.05M |
Source: Nexqual, June 10, 2026 at 14:11 UTC.
Financial Health Score (POSC)
Nexqual rates Positron Corp's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 14:11 UTC.
| Growth | Weak — Revenue -7% YoY (latest Q), declining |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Critical — $1M cash vs $1M debt, net cash position |
| Cash Flow | Weak — Operating cash flow -$4M |
| Efficiency | Mixed — No data |
Ownership (POSC)
| Insider Ownership | +54.64% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 32.85M |
| Float | 14.90M |
Source: Nexqual, June 10, 2026 at 14:11 UTC.
Leadership (POSC)
Positron Corp is led by Adel Abdullah (age 51), President & Chairman, per Nexqual as of June 10, 2026 at 14:11 UTC.
| President & Chairman | Adel Abdullah (age 51) |
|---|---|
| Vice President | Aaron Hargrave (age 39) |
From Positron Corp's Latest SEC 10-K Filing (filed 2026-03-31)
Partnerships
- Food and Drug Administration ("FDA") Quality System Regulation, as well as other federal, state, and international standards, including those applicable within the European Union.   Research and Development   The Company conducts its research and development activities in collaboration with its strategic partner, Neusoft Medical Systems, which provides expertise in the design, engineering, and manufacturing of advanced medical imaging systems.
- Food and Drug Administration ("FDA") 510(k) clearance.   The Company's collaboration with Neusoft also supports the continued development and production of its PET imaging systems and related technologies.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NIMU | Non-Invasive Monitoring Systems | USD 0.06 | ▼ 14.29% |
| ESMC | Escalon Medical Corp. | USD 0.2 | ▲ 5.26% |
| PKTX | ProtoKinetix, Inc. | USD 0.01 | ▼ 6.14% |
| PSCO | Protosource Corp. | USD 0.02 | ▲ 0% |
| NEPH | Nephros, Inc. | USD 3.19 | ▼ 5.87% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 14:11 UTC. This page is informational and not investment advice.